Pharma lobby flags 'cumbersome' export rule, seeks change

Pharma lobby groups are urging for changes to the centralized no-objection certification (NOC) for drug exports due to a significant export decline. The requirement for approvals from importing countries or Indian regulators has increased trade diversions. Industry experts are calling for a review of the provision, citing burdens on exporters and potential stifling of innovation, especially for MSMEs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8D1GLtI
via IFTTT